Skip links

QuarkBio at Tri-Con 2019

Our first exhibition of 2019 takes us to Molecular Med Tri-Con in San Francisco, California. Alongside our partner, AccuBioMed, we are introducing a brand new application on our PanelStation™ system: digital qPCR. PanelStation™, now with dual functionality, has expanded into liquid biopsy digital PCR applications, with our first application detecting EGFR mutation biomarkers (exon 19 deletion, L858R and T790M) to monitor the effectiveness of NSCLC treatments and development of drug resistance in patients, thus providing real-time oncology tracking.

Close Bitnami banner